Asker Healthcare Group AB
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Asker Healthcare Group AB (I88) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.033x
Based on the latest financial reports, Asker Healthcare Group AB (I88) has a cash flow conversion efficiency ratio of 0.033x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€211.00 Million) by net assets (€6.42 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Asker Healthcare Group AB - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Asker Healthcare Group AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Asker Healthcare Group AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Asker Healthcare Group AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zotye Automobile Co Ltd
SHE:000980
|
1.703x |
|
INTER CARS SA ZY 2
F:7FZ
|
N/A |
|
Industrial & Infrastructure Fund Investment Corp
F:2ES
|
0.001x |
|
Shenzhen International Holdings Limited
F:SXYA
|
0.014x |
|
IperionX Limited American Depositary Share
NASDAQ:IPX
|
0.017x |
|
Bank First National Corp
NASDAQ:BFC
|
-0.217x |
|
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
|
0.019x |
|
HomeCo Daily Needs REIT
PINK:HDNRF
|
0.020x |
Annual Cash Flow Conversion Efficiency for Asker Healthcare Group AB (2022–2024)
The table below shows the annual cash flow conversion efficiency of Asker Healthcare Group AB from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €3.50 Billion | €1.23 Billion | 0.350x | +1.28% |
| 2023-12-31 | €3.04 Billion | €1.05 Billion | 0.346x | -1.07% |
| 2022-12-31 | €2.79 Billion | €976.00 Million | 0.350x | -- |